ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer. (Q37023688)
Jump to navigation
Jump to search
scientific article published on 12 October 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer. |
scientific article published on 12 October 2015 |
Statements
ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer (English)
M van Geldermalsen
R Nagarajah
A Thoeng
D Gao
W Ritchie
Y Feng
K Harvey
J M Beith
C I Selinger
S A O'Toole
12 October 2015
1 reference